Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Turpie

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|March 25, 1999
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolismC Kearon, M Gent, J Hirsh, et al.
Archives of Internal Medicine|May 26, 1997
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosisJ S Ginsberg, C Kearon, J Douketis, et al.
Clinical Cardiology|May 22, 1998
Management strategies for a better outcome in unstable coronary artery diseaseR W Campbell, L Wallentin, F W Verheugt, et al.
Thrombosis and Haemostasis|April 1, 2000
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimerP S Wells, D R Anderson, M Rodger, et al.
Lancet (London, England)|September 12, 2001
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trialP M Bath, E Lindenstrom, G Boysen, et al.
Journal of the American College of Cardiology|September 15, 2000
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary EventsS G Goodman, M Cohen, F Bigonzi, et al.
Circulation|October 12, 1999
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trialE M Antman, C H McCabe, E P Gurfinkel, et al.
Journal of Thrombosis and Haemostasis : JTH|April 2, 2015
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN StudyC W Francis, C M Kessler, S Z Goldhaber, et al.
Clinical Cardiology|September 16, 1999
Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD CouncilF W Verheugt, R C Becker, M E Bertrand, et al.
Annals of Internal Medicine|June 1, 1983
Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scanR D Hull, J Hirsh, C J Carter, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|March 25, 1999
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolismC Kearon, M Gent, J Hirsh, et al.
Archives of Internal Medicine|May 26, 1997
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosisJ S Ginsberg, C Kearon, J Douketis, et al.
Clinical Cardiology|May 22, 1998
Management strategies for a better outcome in unstable coronary artery diseaseR W Campbell, L Wallentin, F W Verheugt, et al.
Thrombosis and Haemostasis|April 1, 2000
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimerP S Wells, D R Anderson, M Rodger, et al.
Lancet (London, England)|September 12, 2001
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trialP M Bath, E Lindenstrom, G Boysen, et al.
Journal of the American College of Cardiology|September 15, 2000
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary EventsS G Goodman, M Cohen, F Bigonzi, et al.
Circulation|October 12, 1999
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trialE M Antman, C H McCabe, E P Gurfinkel, et al.
Journal of Thrombosis and Haemostasis : JTH|April 2, 2015
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN StudyC W Francis, C M Kessler, S Z Goldhaber, et al.
Clinical Cardiology|September 16, 1999
Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD CouncilF W Verheugt, R C Becker, M E Bertrand, et al.
Annals of Internal Medicine|June 1, 1983
Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scanR D Hull, J Hirsh, C J Carter, et al.
Pageof 18